Christiane Neuhof, 11Department of Internal Medicine, Division of Cardiology, University of Giessen and Marburg, D-35392 Giessen, Germany
Verena Fabiunke, 22Department of Internal Medicine, Division of Cardiology, University of Giessen and Marburg, D-35392 Giessen, Germany
Maria Speth, 33Institute of Clinical Chemistry and Pathobiochemistry, University of Giessen and Marburg, D-35392 Giessen, Germany
Achim Möller, 44Neuroscience Discovery Research, Abbott GmbH & Co. KG, D-67008 Ludwigshafen, Germany
Hans Fritz, 55Department of Surgery, Division of Clinical Chemistry and Clinical Biochemistry, Ludwig Maximilians University of Munich, D-80336 Munich, Germany
Harald Tillmanns, 66Department of Internal Medicine, Division of Cardiology, University of Giessen and Marburg, D-35392 Giessen, Germany
Heinz Neuhof, 77Department of Internal Medicine, Division of Cardiology, University of Giessen and Marburg, D-35392 Giessen, Germany
Ali Erdogan, 88Department of Internal Medicine, Division of Cardiology, University of Giessen and Marburg, D-35392 Giessen, Germany
Corresponding author

Citation Information. Biological Chemistry. Volume 389, Issue 12, Pages 1505–1512, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2008.172, December 2008
Publication History: Received: 22/6/2008; accepted: 8/9/2008; published online: 11/12/2008
Abstract
The calpain inhibitor A-705253 and the Na+/H+-exchange inhibitor Cariporide® were studied in isolated perfused rabbit hearts subjected to 60 min occlusion of the ramus interventricularis of the left coronary artery (below the origin of the first diagonal branch), followed by 120 min of reperfusion. The inhibitors were added to the perfusion fluid solely or in combination at the beginning of reperfusion. Hemodynamic monitoring and biochemical analysis of perfusion fluid from the coronary outflow were performed. Myocardial infarct size and area at risk (transiently not perfused myocardium) were determined from left ventricular slices after a special staining procedure with Evans blue and 2,3,5-triphenyltetrazolium chloride. The infarcted area (dead myocardium) was 72.7±4.0% of the area at risk in untreated controls, but was significantly smaller in the presence of the inhibitors. The largest effect was observed with 10-6 M A-705253, which reduced the infarcted area to 49.2±4.1% of the area at risk, corresponding to a reduction of 33.6%. Cariporide® at 10-6 M reduced the infarct size to the same extent. The combination of both inhibitors, however, did not further improve cardioprotection. No significant difference was observed between the experimental groups in coronary perfusion, left ventricular pressure, heart rate, or in the release of lactate dehydrogenase and creatine kinase from heart muscle.
Keywords coronary occlusion, coronary perfusion, enzyme release, infarct size, left ventricular pressure